7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid
カタログ番号 T36999 CAS
887752-13-8
Novel oxylipins, referred to as docosanoids, have been derived from C22polyunsaturated fatty acids 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic acid (7(S),17(S)-hydroxy DPA) is a DPA-derived analog of the 17(S)-dihydroxy series of docosanoids known as protectins. Protectin D1, a DHA-derived dihydroxy fatty acid, exhibits potent anti-inflammatory activities.1,2,3Potentially, 7(S),17(S)-hydroxy DPA demonstrates similar properties; however, its biological activity has yet to be determined.
TargetMolの製品は全て研究用試薬です。人体にはご使用できません。
また、個人の方への販売は行っておりません。
7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid, CAS 887752-13-8
パッケージサイズ |
在庫状況 |
単価(税別) |
25 μg |
約 35 days |
¥ 26,000 |
50 μg |
約 35 days |
¥ 49,000 |
100 μg |
約 35 days |
¥ 90,000 |
1. 1研究室・グループあたり最大5製品までお申し込みいただけます。 同一製品は1回のみとなります。
2. 1回につき最大2製品までのお申し込みが可能です。
3. 2回目以降をご希望の際は、前回ご提供のサンプルの実験結果をオンラインでご提供いただく必要がございます。
4. 2023 年 1 月 20 日より前にサンプルをお申し込みいただいたお客様は、2023 年の無料申請枠にはカウントされませんが、以前の実験結果をご提供いただく必要があります。
生物学的特性に関する説明
化学的特性
保存条件
& 溶解度情報
説明 |
Novel oxylipins, referred to as docosanoids, have been derived from C22polyunsaturated fatty acids 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic acid (7(S),17(S)-hydroxy DPA) is a DPA-derived analog of the 17(S)-dihydroxy series of docosanoids known as protectins. Protectin D1, a DHA-derived dihydroxy fatty acid, exhibits potent anti-inflammatory activities.1,2,3Potentially, 7(S),17(S)-hydroxy DPA demonstrates similar properties; however, its biological activity has yet to be determined. |
分子量 |
362.51
|
分子式 |
C22H34O4 |
CAS No. |
887752-13-8 |
保存条件
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度情報
DMF: 100 mg/mL
Ethanol: Miscible
DMSO: 100 mg/mL
参考文献
1.
Serhan, C.N., Gotlinger, K., Hong, S., et al.Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: Assignments of dihydroxy-containing docosatrienesJ. Immunol.176(3)1848-1859(2006)
2.
Ariel, A., and Serhan, C.N.Resolvins and protectins in the termination program of acute inflammationTRENDS in Immunology28(4)176-183(2007)
3.
Schwab, J.M., Chiang, N., Arita, M., et al.Resolvin E1 and protectin D1 activate inflammation-resolution programmesNature447(7146)869-874(2007)
投与量変換
You can also refer to dose conversion for different animals.
詳細
In vivo投与量計算 (透明溶液)
ステップ1: 以下の情報を入力してください
溶媒の組成を入力してください
計算器
モル濃度計算機
希釈計算機
再構成計算
分子量計算機
bottom
技術サポート
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Keywords
7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid
887752-13-8
7(S),17(S) dihydroxy 8(E),10(Z),13(Z),15(E),19(Z) Docosapentaenoic Acid
7,17dihydroxy-8,10,13,15,19Docosapentaenoic Acid
7(S),17(S)dihydroxy8(E),10(Z),13(Z),15(E),19(Z)Docosapentaenoic Acid
Inhibitor
inhibitor
inhibit